AzTrials
AzTrials

Uptake of Antenatal Health Care ServicesTaabo ANCNCT07341581

Improving Uptake of Antenatal Care Services in Rural Côte d'Ivoire

A study testing Information video, Financial planning session and Vouchers in people with Uptake of Antenatal Health Care Services, run by Swiss Tropical & Public Health Institute at 1 site in Côte d’Ivoire.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The past two decades have brought significant increases in the availability of maternal health care services in many low- and middle-income countries, with a large increase in the number of health facilities that provide these services. Read more about this study

Who is it for?
Ages 15 years and older, women only
Conditions the study is for
Uptake of Antenatal Health Care Services
What is being tested?
Information video, Financial planning session and Vouchers
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,290 participants
Where
1 siteCôte d’Ivoire
Study dates
16 Jan 2026to Feb 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 years and older
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Currently pregnant
  • Aged 15 years or older
  • Live in the area served by the Taabo Health \& Demographic Surveillance System
  • Estimated gestational age of less than 6 completed months of pregnancy
  • Aged 15 and older
  • Married to or currently the main romantic partner of a woman who is enrolled in the study

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Côte d’Ivoire1 site, 1 recruiting
  • Centre Suisse de Recherches Scientifiques en Cote d'Ivoire

    Taabo

    Siaka Koné, PhD, +2250749069627, Siaka.kone@csrs.ci

    Recruiting

Other trials in Côte d’Ivoire

About this study

Official title: Supply and Demand-Side Interventions to Improve Uptake of Antenatal Care Services: a Randomized Controlled Trial in Rural Côte d'Ivoire

The past two decades have brought significant increases in the availability of maternal health care services in many low- and middle-income countries, with a large increase in the number of health facilities that provide these services. However, many women still do not receive the basic services recommended by the World Health Organization. In many settings, antenatal care is associated with substantial financial cost, which means that obtaining high quality care can involve complex intrahousehold bargaining and decision-making. Women have more access to information about these services, but men generally make the financial decisions. If men are unaware of the magnitude and timing of financial needs, securing adequate financial resources may be difficult.

The investigators plan to conduct a randomized-controlled experiment of supply- and demand-side solutions to increase uptake of recommended antenatal care services in rural Côte d'Ivoire, where there are currently substantial gaps in service coverage. Despite Côte d'Ivoire's "free maternity care" policy, many recommended services - including ultrasounds and laboratory tests - continue to carry costs for patients. On the supply side, the study will evaluate the impact of providing key services (including ultrasounds, laboratory testing, and iron and folic acid supplements) for free to pregnant women (in line with Côte d'Ivoire's policy of free provision). On the demand side, the study will evaluate the impact of providing information about antenatal care recommendations to pregnant women (alone or with their partners), and of providing a financial planning session to pregnant women or their partners, or both together. The study will evaluate the impacts of these interventions on the uptake of recommended antenatal care services.

Read the detailed description

The past two decades have seen significant increases in the uptake of antenatal care (ANC) and facility-based childbirth in low- and middle-income countries (LMICs), driven by expansions in health service availability, reductions in user fees, and introductions of public insurance programs that make services accessible to a larger portion of the population. However, in many cases, expansions in service coverage have not translated into the anticipated improvements in health outcomes.

One of the primary reasons why increases in coverage have not yielded the desired improvements in health outcomes is the low quality of health care services provided in many health facilities in LMICs. These quality gaps appear to be particularly large for women of lower socioeconomic status, who not only tend to attend lower quality health facilities than wealthier or more educated women, but also tend to receive lower quality care within the same health facilities. In many settings, antenatal care is associated with substantial financial cost, which means that obtaining high quality care can involve complex intrahousehold bargaining and decision-making. Women have more access to information about these services, but men generally make the financial decisions. If men are unaware of the magnitude and timing of financial needs, securing adequate financial resources may be difficult.

In Taabo, Côte d'Ivoire, the investigators recently completed a mixed-methods pilot study examining the reasons for gaps in the quality of antenatal care. They found that, while 91% of women attended at least one antenatal care visit, only 44% had the recommended minimum 4 visits. Many also missed out on important recommended services. They found that only 79% of women received at least 1 and only 17% of women received at least 2 ultrasounds over the course of their pregnancies. Only 73% had any laboratory testing (e.g., a blood test to check for anemia). Only 60% reported taking iron and folic acid supplements 30 days per month during their pregnancy. In qualitative interviews, women identified the cost of services as a critical barrier affecting their uptake. Despite Côte d'Ivoire's "free maternity care" policy, many recommended services - including ultrasounds and laboratory tests - continue to carry costs for patients. Qualitative interviews with women raised several potential pathways through which antenatal care service costs could affect uptake. Firstly, in some cases, the services may be unaffordable for some women and their partners. Secondly, a lack of clarity around service prices - particularly in the context of a publicized "free maternity care policy" - makes it challenging for women and their partners to plan for their antenatal care expenditures. Finally, husbands (or male partners) are the main financial decision-makers in many households in the study setting, and they are not always willing to provide resources to cover the costs of antenatal care services.

The investigators plan to conduct a randomized-controlled experiment of supply- and demand-side solutions to increase uptake of recommended antenatal care services. On the supply side, the study will evaluate the impact of providing key services (including ultrasounds, laboratory testing, and iron and folic acid supplements) for free to pregnant women, in line with Côte d'Ivoire's national "free maternity care" policy. On the demand side, the study will evaluate the impact of providing information about antenatal care recommendations to pregnant women (alone or with their partners), and of providing a financial planning session to pregnant women or their partners, or both together. The study will evaluate the impacts of these interventions on the uptake of recommended antenatal care services.

Being tested
Information video, Financial planning session, Vouchers
Keywords
maternal health, sub-Saharan Africa, antenatal care, vouchers, financing

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Information videoBehavioural

    Participants will be shown a short video that describes key recommendations for antenatal care and health during pregnancy, based on national guidelines in Côte d'Ivoire. In arms (1a-1b) and (2a-2b), this video will be shown only to the pregnant woman. In arms (3a-3b), this video will be shown to the pregnant woman together with her partner.

  • Financial planning sessionBehavioural

    In this intervention, a member of the study team will facilitate a structured discussion about planning for the expenses of health care services and related transportation costs over the course of pregnancy. The discussion will follow a series of questions and prompts set up as a survey form in ODK (attached to this protocol). The study team member will also share a list of the local prices of recommended antenatal care services. In arms (2a-2b), this intervention is delivered only to pregnant women. In arms (3a-3b), this intervention is delivered to pregnant women together with their partners.

  • VouchersOther

    This intervention consists of vouchers for a pre-defined set of antenatal care services. Pregnant women who are randomized to receive this intervention will be given vouchers for one ultrasound, one "bilan prenatal" (a recommended set of prenatal laboratory tests in Côte d'Ivoire), and a 6-month supply of iron \& folic acid supplements (with dosage based on their health care provider's recommendation). The study team will establish agreements with local health facilities to provide services in exchange for these vouchers, with reimbursement by the study team.

Study groups in NCT07341581
Study groupRoleWhat they receive
1a) Information video onlyExperimentalParticipants in this arm will be shown a short video that describes key recommendations for antenatal care and health during pregnancy, based on national guidelines in Côte d'Ivoire.
Receives: Behavioral: Information video
1b) Information video + VouchersExperimentalParticipants in this arm will be shown a short video that describes key recommendations for antenatal care and health during pregnancy, based on national guidelines in Côte d'Ivoire. They will also receive vouchers to cover the costs of a set of key antenatal health care services.
Receives: Behavioral: Information video; Other: Vouchers
2a) Information video + financial planningExperimentalParticipants in this arm will be shown a short video that describes key recommendations for antenatal care and health during pregnancy, based on national guidelines in Côte d'Ivoire. They will also receive a financial planning session facilitated by a member of the study team.
Receives: Behavioral: Information video; Behavioral: Financial planning session
2b) Information video + financial planning + vouchersExperimentalParticipants in this arm will be shown a short video that describes key recommendations for antenatal care and health during pregnancy, based on national guidelines in Côte d'Ivoire. They will also receive a financial planning session facilitated by a member of the study team. Finally, they will also receive vouchers to cover the costs of a set of key antenatal health care services.
Receives: Behavioral: Information video; Behavioral: Financial planning session; Other: Vouchers
3a) Information video + financial planning with partnersExperimentalParticipants in this arm will be shown a short video that describes key recommendations for antenatal care and health during pregnancy, based on national guidelines in Côte d'Ivoire. They will view it a first time alone, and a second time with their partners. They will also receive a financial planning session facilitated by a member of the study team, together with their partners.
Receives: Behavioral: Information video; Behavioral: Financial planning session
3b) Information video + financial planning with partners + vouchersExperimentalParticipants in this arm will be shown a short video that describes key recommendations for antenatal care and health during pregnancy, based on national guidelines in Côte d'Ivoire. They will view it a first time alone, and a second time with their partners. They will also receive a financial planning session facilitated by a member of the study team, together with their partners. Finally, they will also receive vouchers to cover the costs of a set of key antenatal health care services.
Receives: Behavioral: Information video; Behavioral: Financial planning session; Other: Vouchers

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of women receiving recommended antenatal care services

    The primary endpoint is the proportion of women receiving the following recommended antenatal care services during their pregnancy, as measured through recall during endline surveys with pregnant women:

    • At least four antenatal care visits with a skilled provider AND
    • At least one ultrasound AND
    • At least one laboratory assessment.

    Measured: During pregnancy (measured 4-8 weeks after the end of pregnancy)

Secondary outcomes (8)
  1. Proportion of participants receiving the recommended number of malaria chemoprophylaxis doses during pregnancy

    Proportion of participants who receive at least three doses of malaria chemoprophylaxis during pregnancy as reported by study participants during endline interviews

    Measured: During pregnancy (measured 4-8 weeks after the end of pregnancy)

  2. Proportion of participants receiving high-quality antenatal care measured using antenatal care booklets

    High-quality antenatal care (defined as at least 4 antenatal care visits with a skilled provider, at least one ultrasound, and at least one laboratory assessment) as measured through review of antenatal care booklets (as opposed to measurement by maternal recall). This secondary endpoint will only be measured in cases when women have an ANC book available at the time of the endline interview.

    Measured: During pregnancy (measured 4-8 weeks after the end of pregnancy)

  3. Average antenatal care knowledge scores among pregnant women and their partners

    Average scores (among pregnant women and among their partners) on assessments of knowledge of antenatal care recommendations, as measured using the following questions during endline surveys with pregnant women and their partners:

    1. During antenatal care visits, health care providers conduct some examinations and tests. Can you tell me which examinations and tests they should conduct?
    2. During antenatal care visits, health care providers also sometimes give medications or treatments. Can you tell me which medications they should provide to all pregnant women?

    Participants receive 1 point for each correct test or examination they mention in response to Q1 and 1 point for each correct medication or treatment they mention in response to Q2.

    Measured: Measured 4-8 weeks after the end of pregnancy

  4. Proportion of women who delayed or missed care for financial reasons

    Proportion of women who respond "yes" to one or both of the following questions during endline surveys:

    • During your most recent pregnancy, did you ever delay your visit to the hospital because of financial issues?
    • During your most recent pregnancy, did you ever skip recommended care - like an ultrasound or a blood test - because of money problems?

    Measured: Measured 4-8 weeks after the end of pregnancy

  5. Proportion of women who are satisfied with the antenatal care health services that they received

    Proportion of women responding "Excellent" or "Very good" to the question, "How would you rate the overall quality of care you received during your most recent pregnancy? Excellent, Very good, Good, Fair, Poor."

    Measured: Measured 4-8 weeks after the end of pregnancy

  6. Proportion of fathers involved in early care-giving activities

    Proportion of mothers who respond "everyday" or "most days" to the following question during endline surveys: "How often does the father of the child participate in daily care activities such as feeding, bathing, or changing diapers? Every day, most days, some days, or never."

    Measured: Measured 4-8 weeks after the end of pregnancy

  7. Perinatal mortality as reported by women during endline surveys

    Mortality between 28 weeks of pregnancy and 7 days after birth, as reported by women during endline surveys

    Measured: Measured 4-8 weeks after the end of pregnancy

  8. Birthweight as reported by women during endline surveys

    Birthweight in grams, as reported by women during endline surveys

    Measured: Measured 4-8 weeks after the end of pregnancy

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jan 2026
  2. Study start16 Jan 2026
  3. Primary completionFeb 2027 (estimated)
  4. Study completionFeb 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study consists of a randomized controlled experiment with pregnant women. All participants will receive basic antenatal care information through a newly developed introduction video. In addition, participants will be randomly assigned to one of three groups: * (1) Control (Information video only for pregnant women) * (2) Information video + financial planning for pregnant women only * (3) Information video + financial planning for couples together Following randomization to a one of the above groups, 10% of women in each group will be randomized to receive vouchers to cover the costs of a set of key antenatal health care services.
Masking
Single blind
Who is masked
Investigator
Enrolment
1,290 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07341581
Sponsor's protocol ID
2025-40
Acronym
Taabo ANC
Status last verified
Jan 2026
First submitted
19 Dec 2025
Last updated
22 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified data files and analytic code will be posted on public repositories at the time of publication of results.

Questions about this trial

What is this clinical trial studying?

A study testing Information video, Financial planning session and Vouchers in people with Uptake of Antenatal Health Care Services, run by Swiss Tropical & Public Health Institute at 1 site in Côte d’Ivoire.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 22 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Côte d’Ivoire. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of women receiving recommended antenatal care services (time frame: During pregnancy (measured 4-8 weeks after the end of pregnancy)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in